ImageneBio raises ~$30M via pre-funded warrants to fund atopic dermatitis and alopecia areata programs

ImageneBio, Inc.

Gross proceeds of ~$30M from sale of pre-funded warrants for 5.77M shares at $5.199 each.
Closing expected April 14, 2026; warrants exercisable at $0.001, no expiration.
Proceeds to fund late-phase development in atopic dermatitis and expand IMG-007 into alopecia areata.
Registration rights agreement requires filing by early August 2026; cash penalties for delays.
Beneficial ownership limitation set at 19.99% per investor.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

ImageneBio, Inc. issued up to 5,770,335 Warrant Shares of warrant to certain institutional and accredited investors for purchase price of $5.199 per Warrant Share.

Security: warrant
Shares: up to 5,770,335 Warrant Shares
Purchaser: certain institutional and accredited investors
Consideration: purchase price of $5.199 per Warrant Share

Exact text from the filing

pre-funded warrants to purchase up to 5,770,335 Warrant Shares at a purchase price of $5.199 per Warrant Share to the Investors for gross proceeds to the Company of approximately $30 million

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ImageneBio, Inc. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at gross proceeds to the Company of approximately $30 million (effective 2026-04-12).

Action: entry
Agreement: equity purchase
Counterparty: certain institutional and accredited investors
Value: gross proceeds to the Company of approximately $30 million
Effective: 2026-04-12

Exact text from the filing

On April 12, 2026, ImageneBio, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company agreed to sell and issue pre-funded warrants to purchase shares of the Company’s voting common stock

View on SEC.gov

Browse all equity issuances →

ImageneBio, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-151942

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.